Education + Patient Navigation for Cancer Screening
(NYC CONNECT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores ways to boost cancer screening rates for breast, cervical, and colorectal cancers. Researchers are testing whether combining community health worker support (Patient Navigation Services) with customized educational materials is more effective than providing education alone. The trial seeks men and women who are due for cancer screenings and speak English, Spanish, Haitian-Creole, French, or Chinese. Participants should live in certain neighborhoods in New York City and have no prior cancer diagnosis.
As an unphased trial, this study offers participants the chance to contribute to innovative strategies that could enhance cancer screening rates in their communities.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on cancer screening and education, so it's unlikely that your medications will be affected, but you should confirm with the trial organizers.
What prior data suggests that these strategies are safe for increasing cancer screening rates?
Research shows that patient navigation programs are generally safe and easy for people to use. These programs involve community health workers who guide patients through the healthcare system, especially for cancer screenings like breast, cervical, and colorectal cancer.
Studies have found that these programs help patients complete their screenings more quickly and effectively. One study showed that patient navigation services assist patients in overcoming obstacles to getting necessary screenings, such as scheduling, insurance, and other non-medical issues.
These programs have been successfully used in different healthcare systems, indicating their safety in similar settings. No reports of safety concerns or negative effects have been directly linked to patient navigation services, making them a dependable option for supporting patients in their healthcare journey.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how patient navigation (PN), both less intensive and more intensive, can enhance cancer screening outcomes. Unlike traditional methods that often rely heavily on patients navigating the healthcare system alone, these PN approaches provide personalized support through community health workers (CHWs). The more intensive PN includes additional guidance on social services and culturally tailored education, which could improve access and adherence to cancer screening, especially in underserved communities. This trial aims to find out whether such comprehensive support can lead to better screening rates and earlier detection, potentially transforming how preventative care is delivered.
What evidence suggests that this trial's treatments could be effective for increasing cancer screening rates?
Research has shown that community health workers can significantly increase breast, cervical, and colorectal cancer screening rates. In this trial, participants in the Patient Navigation (PN) arm will receive navigation for cancer screening from community health workers, a method proven to help patients overcome obstacles and complete screenings on time. Specifically, low-income minority patients experienced a better quality of life with assistance from community health workers. Participants in the Less Intensive (LI) arm will receive culturally relevant educational materials, which also encourage screening. Together, these strategies effectively raise cancer screening rates, making them promising methods for improving early cancer detection.15678
Who Is on the Research Team?
Chau Trinh, PhD
Principal Investigator
NYU Langone Health
Are You a Good Fit for This Trial?
This trial is for English, Spanish, Haitian-Creole, or Chinese Mandarin speakers in specific NYC areas who are due for breast, cervical, or colorectal cancer screenings. Women should be 21-75 years old and men 50-75. Exclusions include those with total colectomy, current cancer navigation program participants, hospice care patients, certain advanced illnesses or long-term institution residents over 66 years old.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive culturally and linguistically tailored cancer education and navigation services for cancer screening
Follow-up
Participants are monitored for cancer screening completion and social service needs
Optional Extension
Participants in the LI arm may opt to receive full navigational support provided to the PN arm
What Are the Treatments Tested in This Trial?
Interventions
- Educational Materials
- Patient Navigation (PN) - Less Intensive
- Patient Navigation (PN) - More Intensive
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
Centers for Disease Control and Prevention
Collaborator